- Are you involved in the response to HIV and hepatitis C? Transforming our practice: New knowledge, new strategies Thursday, November 23 to Friday, November ...
- Odefsey is the name of a fixed-dose co-formulation of three anti-HIV drugs: tenofovir alafenamide (TAF), emtricitabine (FTC) and rilpivirine.
- CATIE NewsIn Canada and other high-income countries much progress has been made in reducing the risk of HIV transmission from mother to child in the past several decades. ...
- CATIE NewsStudies have found that some HIV-positive people are at heightened risk for cardiovascular disease. The reasons for this are not clear but may be due to one or ...
- This guideline is intended to guide health care providers caring for persons who have experienced significant exposure to blood and/or body fluids in the work place or community setting.
- CATIE NewsMore HIV-positive people are living longer thanks to the use of potent combination anti-HIV therapy (ART). As HIV-positive people enter their middle age and ...
- CATIE NewsThe bacteria that cause the sexually transmitted infection (STI) gonorrhea have been developing resistance to potent antibiotics since the mid-20th century when ...